Navigation Links
Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines

There is an increased Gold rush for Bird flu vaccines and drugs world wide with increased demand in United States.// Due to shortage of vaccines for bird flu vaccines the US has given contract to the Pharmaceutical Company Chiron Corporation to produce Bird flu vaccine. The contract is worth $62.5 million to produce the vaccines to encounter the demand.

US Health Secretary Mike Leavitt said the move would address a shortfall in the nation's vaccine stockpile and said, 'The hard truth is that capacity doesn't exist within the United States to produce vaccines of sufficient speed and in sufficient quantity to reach every American.'

Chiron corporation is to produce flu vaccine from the inactivated flu strain H5N1 through tissue culture the production will be done in its factory in Liverpool, England. Chiron is expected to complete its production and deliver the stocks to the public in US by the starting of 2006.

(IANS)

Avian Influenza or Bird Flu:

This is also commonly called bird flu. Although the disease mainly spreads from birds to other animal species, even to humans, In the avian form, the disease is borne by wild birds, especially ducks, and so it may be difficult to contain the spread of the disease. The first cases of humans being infected by the strain of H5N1 avian influenza were reported in January 2004 in Thailand and Vietnam.
'"/>




Page: 1

Related medicine news :

1. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
2. Patient Refuses To Be Treated In Local Hospital Due To The Fear Of Contracting MRSA
3. New Government Contract Forces Dentists To Quit The NHS
4. Staff Nurses Contract Measles from the Patient
5. One in Ten NHS Dentists Refused To Sign the New Contract
6. Almost 30 Percent Dentists Refuse To Sign NHS Contracts
7. 31 Year Old Man Critical And Is Suspected To Have Contracted Bird Flu Virus In Shenzhen
8. Public Service in South Africa at a High Risk of Contracting AIDS
9. Dengue In City: KMC To Appoint 30 Contract Doctors
10. Patient and Staff of Two Hospitals at Risk Of Contracting TB
11. NHS Dentists Shortage worsens over New Contracts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: